Terug
14
Dagbereik
€ 5,01
€ 5,19
52-Weeksbereik
€ 4,25
€ 8,69
Volume
1.706.850
50D / 200D Gem.
€ 5,98
/
€ 6,45
Vorige Slotkoers
€ 5,01
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 12,2 | 0,4 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | 1,5 | 3,9 |
| Rev Growth 5Y % | 5,2 | 10,0 |
| D/E | — | 0,2 |
Koersdoel Analisten
Hold
€ 8,00
+56.9%
Forward K/W
1,2
Forward WPA
€ 4,36
WPA Groei (sch.)
+0,0%
Omzet Sch.
11 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 3,59
€ 3,57 – € 3,62
|
9,7 B | 1 |
| FY2029 |
€ 3,33
€ 3,31 – € 3,35
|
9,7 B | 1 |
| FY2028 |
€ 3,08
€ 3,07 – € 3,10
|
9,8 B | 2 |
Belangrijkste Punten
Revenue grew 5,15% annually over 5 years — modest growth
Generating 1,00B in free cash flow
P/E of 12,17 — trading at a low valuation
Cash machine — converts 645,94% of earnings into free cash flow
Capital efficient — spends only 3,85% of revenue on capex
Interest coverage of 1,37× — tight debt servicing
Groei
Revenue Growth (5Y)
5,15%
Revenue (1Y)7,11%
Earnings (1Y)N/A
FCF Growth (3Y)14,88%
Kwaliteit
Return on Equity
N/A
ROIC7,51%
Net Margin1,51%
Op. Margin20,07%
Veiligheid
Debt / Equity
N/A
Current Ratio1,47
Interest Coverage1,37
Waardering
P/E Ratio
12,17
P/B RatioN/A
EV/EBITDA10,52
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7,11% | Revenue Growth (3Y) | 8,50% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 5,15% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 10,31B | Net Income (TTM) | 155,28M |
| ROE | N/A | ROA | 0,59% |
| Gross Margin | 68,33% | Operating Margin | 20,07% |
| Net Margin | 1,51% | Free Cash Flow (TTM) | 1,00B |
| ROIC | 7,51% | FCF Growth (3Y) | 14,88% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,47 |
| Interest Coverage | 1,37 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 12,17 | P/B Ratio | N/A |
| P/S Ratio | 0,18 | PEG Ratio | -0,04 |
| EV/EBITDA | 10,52 | Dividend Yield | 0,00% |
| Market Cap | 1,89B | Enterprise Value | 21,77B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 10,31B | 9,63B | 8,76B | 8,12B | 8,43B |
| Net Income | 155,28M | -46,00M | -592,00M | -225,00M | -948,00M |
| EPS (Diluted) | 0,41 | -0,13 | -1,62 | -0,62 | -2,61 |
| Gross Profit | 7,04B | 6,84B | 6,20B | 5,76B | 6,04B |
| Operating Income | 2,07B | 1,55B | 963,00M | 454,00M | 450,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 26,32B | 26,52B | 27,35B | 25,69B | 29,20B |
| Total Liabilities | 25,94B | 26,85B | 27,43B | 25,43B | 29,24B |
| Shareholders' Equity | -552,99M | -1,28B | -1,02B | -692,00M | -106,00M |
| Total Debt | 21,21B | 21,83B | 22,39B | 20,77B | 22,65B |
| Cash & Equivalents | 1,32B | 1,18B | 947,00M | 564,00M | 582,00M |
| Current Assets | 6,15B | 5,77B | 5,60B | 4,25B | 5,61B |
| Current Liabilities | 4,17B | 6,75B | 4,30B | 3,94B | 5,20B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#506 of 616
Recente Activiteit
Ingestapt
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026